Vanguard Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $53.8M | Sell |
15,958,196
-113,810
| -0.7% | -$296K | ﹤0.01% | 2126 |
|
|
2025
Q3 | $21.1M | Sell |
16,072,006
-130,123
| -0.8% | -$135K | ﹤0.01% | 2594 |
|
|
2025
Q2 | $11.6M | Buy |
16,202,129
+505,968
| +3% | +$397K | ﹤0.01% | 2819 |
|
|
2025
Q1 | $23.1M | Sell |
15,696,161
-3,842,394
| -20% | -$9.15M | ﹤0.01% | 2447 |
|
|
2024
Q4 | $86.6M | Sell |
19,538,555
-2,499,542
| -11% | -$10.1M | ﹤0.01% | 1931 |
|
|
2024
Q3 | $90.8M | Buy |
22,038,097
+474,683
| +2% | +$2.55M | ﹤0.01% | 1917 |
|
|
2024
Q2 | $141M | Buy |
21,563,414
+2,042,048
| +10% | +$14.4M | ﹤0.01% | 1680 |
|
|
2024
Q1 | $170M | Buy |
19,521,366
+3,487,821
| +22% | +$42.3M | ﹤0.01% | 1611 |
|
|
2023
Q4 | $183M | Buy |
16,033,545
+1,137,845
| +8% | +$11.3M | ﹤0.01% | 1555 |
|
|
2023
Q3 | $143M | Buy |
14,895,700
+49,160
| +0.3% | +$482K | ﹤0.01% | 1607 |
|
|
2023
Q2 | $158M | Sell |
14,846,540
-127,776
| -0.9% | -$1.37M | ﹤0.01% | 1590 |
|
|
2023
Q1 | $158M | Buy |
14,974,316
+241,747
| +2% | +$2.71M | ﹤0.01% | 1581 |
|
|
2022
Q4 | $183M | Buy |
14,732,569
+248,012
| +2% | +$2.81M | 0.01% | 1480 |
|
|
2022
Q3 | $150M | Buy |
14,484,557
+4,733
| +0% | +$53.7K | ﹤0.01% | 1559 |
|
|
2022
Q2 | $167M | Buy |
14,479,824
+1,123,496
| +8% | +$13.2M | ﹤0.01% | 1538 |
|
|
2022
Q1 | $168M | Sell |
13,356,328
-131,434
| -1% | -$1.51M | ﹤0.01% | 1655 |
|
|
2021
Q4 | $157M | Buy |
13,487,762
+31,629
| +0.2% | +$388K | ﹤0.01% | 1734 |
|
|
2021
Q3 | $176M | Sell |
13,456,133
-441,046
| -3% | -$5.7M | ﹤0.01% | 1683 |
|
|
2021
Q2 | $179M | Sell |
13,897,179
-1,800,541
| -11% | -$20.6M | ﹤0.01% | 1688 |
|
|
2021
Q1 | $176M | Sell |
15,697,720
-194,627
| -1% | -$2.06M | ﹤0.01% | 1653 |
|
|
2020
Q4 | $181M | Buy |
15,892,347
+133,929
| +0.8% | +$1.47M | 0.01% | 1517 |
|
|
2020
Q3 | $142M | Sell |
15,758,418
-607,919
| -4% | -$6.04M | ﹤0.01% | 1491 |
|
|
2020
Q2 | $169M | Buy |
16,366,337
+25,147
| +0.2% | +$257K | 0.01% | 1383 |
|
|
2020
Q1 | $165M | Sell |
16,341,190
-297,751
| -2% | -$3.5M | 0.01% | 1242 |
|
|
2019
Q4 | $221M | Sell |
16,638,941
-106,232
| -0.6% | -$1.17M | 0.01% | 1329 |
|
|
2019
Q3 | $144M | Buy |
16,745,173
+1,139,016
| +7% | +$11.1M | 0.01% | 1535 |
|
|
2019
Q2 | $171M | Sell |
15,606,157
-2,233,712
| -13% | -$25M | 0.01% | 1458 |
|
|
2019
Q1 | $202M | Buy |
17,839,869
+1,887,368
| +12% | +$21.1M | 0.01% | 1334 |
|
|
2018
Q4 | $138M | Buy |
15,952,501
+1,236,506
| +8% | +$14.2M | 0.01% | 1476 |
|
|
2018
Q3 | $228M | Buy |
14,715,995
+450,349
| +3% | +$7.12M | 0.01% | 1288 |
|
|
2018
Q2 | $228M | Buy |
14,265,646
+558,069
| +4% | +$8.26M | 0.01% | 1263 |
|
|
2018
Q1 | $177M | Buy |
13,707,577
+245,478
| +2% | +$3.06M | 0.01% | 1365 |
|
|
2017
Q4 | $169M | Buy |
13,462,099
+309,327
| +2% | +$4.04M | 0.01% | 1412 |
|
|
2017
Q3 | $174M | Buy |
13,152,772
+303,103
| +2% | +$4.17M | 0.01% | 1372 |
|
|
2017
Q2 | $203M | Buy |
12,849,669
+306,149
| +2% | +$4.45M | 0.01% | 1222 |
|
|
2017
Q1 | $179M | Buy |
12,543,520
+671,241
| +6% | +$9.18M | 0.01% | 1289 |
|
|
2016
Q4 | $152M | Buy |
11,872,279
+340,229
| +3% | +$4.3M | 0.01% | 1356 |
|
|
2016
Q3 | $153M | Buy |
11,532,050
+332,897
| +3% | +$3.89M | 0.01% | 1284 |
|
|
2016
Q2 | $123M | Buy |
11,199,153
+336,300
| +3% | +$3.29M | 0.01% | 1371 |
|
|
2016
Q1 | $99.5M | Buy |
10,862,853
+342,730
| +3% | +$2.83M | 0.01% | 1488 |
|
|
2015
Q4 | $102M | Buy |
10,520,123
+312,488
| +3% | +$3.02M | 0.01% | 1458 |
|
|
2015
Q3 | $89.1M | Buy |
10,207,635
+280,191
| +3% | +$2.61M | 0.01% | 1513 |
|
|
2015
Q2 | $100M | Buy |
9,927,444
+378,064
| +4% | +$4.39M | 0.01% | 1525 |
|
|
2015
Q1 | $128M | Buy |
9,549,380
+542,146
| +6% | +$7.11M | 0.01% | 1330 |
|
|
2014
Q4 | $116M | Buy |
9,007,234
+271,671
| +3% | +$3.11M | 0.01% | 1316 |
|
|
2014
Q3 | $94.8M | Buy |
8,735,563
+137,801
| +2% | +$1.58M | 0.01% | 1391 |
|
|
2014
Q2 | $110M | Buy |
8,597,762
+65,707
| +0.8% | +$714K | 0.01% | 1328 |
|
|
2014
Q1 | $88M | Buy |
8,532,055
+1,764,732
| +26% | +$19.8M | 0.01% | 1439 |
|
|
2013
Q4 | $65.8M | Buy |
6,767,323
+209,118
| +3% | +$1.88M | 0.01% | 1609 |
|
|
2013
Q3 | $65.1M | Buy |
6,558,205
+405,586
| +7% | +$3.98M | 0.01% | 1542 |
|
|
2013
Q2 | $51.3M | Buy |
+6,152,619
| New | +$74.6M | 0.01% | 1619 |
|
Other funds holding IRWD
AC
SCM
Vanguard Group's IRWD Position: Q4 2025 in Review
Vanguard Group reduced its Ironwood Pharmaceuticals (IRWD) stake by 0.71% in Q4 2025, selling an estimated $296K and leaving 15,958,196 shares worth $53.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2126.
Vanguard Group first reported a position in IRWD in Q2 2013 and has held it in 51 quarters since. The position peaked at $228M in Q2 2018. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2025.
- Vanguard Group held 15,958,196 shares of Ironwood Pharmaceuticals worth $53.8M as of Q4 2025.
- Vanguard Group sold 113,810 Ironwood Pharmaceuticals shares in Q4 2025, an estimated $296K.
- Ironwood Pharmaceuticals made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #2126 holding.
- Vanguard Group first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 51 quarters since.
- Vanguard Group's Ironwood Pharmaceuticals position peaked at $228M in Q2 2018.
- 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2025.
Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.